ZIVALIO-M 500ER Tablets

For better Diabetic Outcome

 

COMPOSITION: Dapagliflozin 10mg + Metformin HCL IP 500mg Tablets

  • Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).
  • Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases.
  • Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.
  • Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.
  • Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus.

INDICATIONS:

  • Diabetes Mellitus
  • Hypoglycemia
  • Cardiovascular Disorders
  • Renal Diseases
  • Highly potent antihyperglycemic agent, beneficial for the treatment of type 2 diabetes (T2D).
  • Outstanding cardioprotective and renoprotective agent, an excellent option for patients with a history of cardiovascular and renal diseases. 
  • Monotherapy as well as combination therapy provides effective glycaemic control, and reduces body weight and blood pressure (BP) across a broad spectrum of patients.
  • Co-administration of dapagliflozin and metformin has a valuable synergistic effect in maintaining blood sugar levels and reduces the incidence of hypoglycemia.
  • Highly effective in both early and late stages of T2DM, this helps in stopping the clinical progression of diabetes mellitus.